Cargando…
High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy with dismal prognosis. Identification of better biomarkers remained a priority to improve established stratification and guide therapeutic decisions. Therefore, we extracted the RNA sequence data and clinical characteristics of...
Autores principales: | Li, Qiaoli, Pan, Hong, Gao, Zhen, Li, Weiwang, Zhang, Lele, Zhao, Jingyu, Fang, Liwei, Chu, Yajing, Yuan, Weiping, Shi, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891309/ https://www.ncbi.nlm.nih.gov/pubmed/36741319 http://dx.doi.org/10.3389/fgene.2023.1063227 |
Ejemplares similares
-
P1242: A TRUELY LEUKEMIC SUBPOPULATION IDENTIFIED BY SINGLE CELL SEQUENCING IN T LARGE GRANULAR LYMPHOCYTIC LEUKEMIA
por: Zhang, Lele, et al.
Publicado: (2023) -
High Expression of DC-STAMP Gene Predicts Adverse Outcomes in AML
por: Liang, Qian, et al.
Publicado: (2022) -
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine
por: Zhang, Lele, et al.
Publicado: (2023) -
P753: TARGETING IL-2-INDUCIBLE T CELL KINASE (ITK) TO BLOCK T LYMPHOCYTE ACTIVATION FOR THE TREATMENT OF APLASTIC ANEMIA MURINE MODEL
por: LI, Weiwang, et al.
Publicado: (2023) -
P582: AZACITIDINE COMBINED WITH HAG REGIMEN AS INDUCTION THERAPY IN ADULT AML PATIENTS
por: Pan, Hong, et al.
Publicado: (2023)